Similar articles

• Abrogation of anterior-chamber-induced suppression of delayed-type hypersensitivity responses by monoclonal anti-I-J antibodies.

  Niederkorn JY, Waltenbaugh C, Streilein JW. Niederkorn JY, et al. Transplantation. 1984 Jun;37(6):623-5. Transplantation. 1984. PMID: 6233772 No abstract available.
• Tumour-specific CTL response requiring interactions of four different cell types and recognition of MHC class I and class II restricted tumour antigens.

  Schirrmacher V, Schild HJ, Gückel B, von Hoegen P. Schirrmacher V, et al. Immunol Cell Biol. 1993 Aug;71 ( Pt 4):311-26. doi: 10.1038/icb.1993.36. Immunol Cell Biol. 1993. PMID: 7901150
• Induction of suppressor T cells by intravenous administration of monoclonal anti-I-A antibody.

  Aoki I, Ishii N, Minami M, Nagashima Y, Misugi K, Okuda K. Aoki I, et al. Transplantation. 1987 Sep;44(3):421-5. doi: 10.1097/00007890-198709000-00019. Transplantation. 1987. PMID: 2957838
• In vivo effects of antibodies to immune response gene products. II. Suppression of humoral immune responses with monoclonal anti-I-A is due to suppressor cells.

  Adelman NE, Watling D, McDevitt HO. Adelman NE, et al. Int Rev Immunol. 1988 Aug;3(4):333-44. doi: 10.3109/08830188809051201. Int Rev Immunol. 1988. PMID: 2854550 Review. No abstract available.
• Suppressor T cells: some answers but more questions.

  Dorf ME, Kuchroo VK, Collins M. Dorf ME, et al. Immunol Today. 1992 Jul;13(7):241-3. doi: 10.1016/0167-5699(92)90002-O. Immunol Today. 1992. PMID: 1388648 Review.